Exploring the pharmacodynamic substance basis of Ginseng-Polygala-Poria-Cervi Cornu compound prescription against Alzheimer's disease based on HPLC-MS and network pharmacologyOA
Exploring the pharmacodynamic substance basis of Ginseng-Polygala-Poria-Cervi Cornu compound prescription against Alzheimer's disease based on HPLC-MS and network pharmacology
Bo Chen;Liu-Wei Xie;Yang Dong;Guan-Lin Li;Yang Yang
Department of Neurology,The Second Affiliated Hospital of Shenyang Medical College,Shenyang 110034,ChinaPolice Dog Technology College,Criminal Investigation Police University of China,Shenyang 110854,ChinaDepartment of Neurology,The Second Affiliated Hospital of Shenyang Medical College,Shenyang 110034,ChinaPolice Dog Technology College,Criminal Investigation Police University of China,Shenyang 110854,ChinaDepartment of Neurology,The Second Affiliated Hospital of Shenyang Medical College,Shenyang 110034,China
Ginseng-Polygala-Poria-Cervi Cornu compoundbrain tissue damagecognitive dysfunctionLC-MSnetwork pharmacologyPI3K/AKT signaling pathway
Ginseng-Polygala-Poria-Cervi Cornu compoundbrain tissue damagecognitive dysfunctionLC-MSnetwork pharmacologyPI3K/AKT signaling pathway
《传统医学研究（英文版）》 2026 (9)
15-30,16
This work was supported by a research project funded by the Liaoning Provincial Department of Science and Technology(Nos.2024-MS-223).
评论